Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy

Colorectal cancer (CRC) is a prevalent disease worldwide, and patients at late stages of CRC often suffer from a high mortality rate after surgery. Adjuvant chemotherapeutics (ACs) have been extensively developed to improve the survival rate of such patients, but conventionally formulated ACs inevit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chunhua, Merlin, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408503/
https://www.ncbi.nlm.nih.gov/pubmed/32708193
http://dx.doi.org/10.3390/nano10071424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408503/
https://www.ncbi.nlm.nih.gov/pubmed/32708193
http://dx.doi.org/10.3390/nano10071424

Ejemplares similares